Efficacy and Tolerability of Gefapixant for Treatment of Refractory or Unexplained Chronic Cough: A Systematic Review and Dose-Response Meta-Analysis.

MLA

Kum, Elena, et al. “Efficacy and Tolerability of Gefapixant for Treatment of Refractory or Unexplained Chronic Cough: A Systematic Review and Dose-Response Meta-Analysis.” JAMA, vol. 330, no. 14, Oct. 2023, pp. 1359–69. EBSCOhost, https://doi.org/10.1001/jama.2023.18035.

APA

Kum, E., Patel, M., Diab, N., Wahab, M., Zeraatkar, D., Chu, D. K., O’Byrne, P. M., Guyatt, G. H., & Satia, I. (2023). Efficacy and Tolerability of Gefapixant for Treatment of Refractory or Unexplained Chronic Cough: A Systematic Review and Dose-Response Meta-Analysis. JAMA, 330(14), 1359–1369. https://doi.org/10.1001/jama.2023.18035

Chicago

Kum, Elena, Matthew Patel, Nermin Diab, Mustafaa Wahab, Dena Zeraatkar, Derek K Chu, Paul M O’Byrne, Gordon H Guyatt, and Imran Satia. 2023. “Efficacy and Tolerability of Gefapixant for Treatment of Refractory or Unexplained Chronic Cough: A Systematic Review and Dose-Response Meta-Analysis.” JAMA 330 (14): 1359–69. doi:10.1001/jama.2023.18035.